» Articles » PMID: 29779700

Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction

Abstract

Despite substantial declines in mortality following myocardial infarction (MI), subsequent left ventricular remodeling (LVRm) remains a significant long-term complication. Extracellular small non-coding RNAs (exRNAs) have been associated with cardiac inflammation and fibrosis and we hypothesized that they are associated with post-MI LVRm phenotypes. RNA sequencing of exRNAs was performed on plasma samples from patients with "beneficial" (decrease LVESVI ≥ 20%, n = 11) and "adverse" (increase LVESVI ≥ 15%, n = 11) LVRm. Selected differentially expressed exRNAs were validated by RT-qPCR (n = 331) and analyzed for their association with LVRm determined by cardiac MRI. Principal components of exRNAs were associated with LVRm phenotypes post-MI; specifically, LV mass, LV ejection fraction, LV end systolic volume index, and fibrosis. We then investigated the temporal regulation and cellular origin of exRNAs in murine and cell models and found that: 1) plasma and tissue miRNA expression was temporally regulated; 2) the majority of the miRNAs were increased acutely in tissue and at sub-acute or chronic time-points in plasma; 3) miRNA expression was cell-specific; and 4) cardiomyocytes release a subset of the identified miRNAs packaged in exosomes into culture media in response to hypoxia/reoxygenation. In conclusion, we find that plasma exRNAs are temporally regulated and are associated with measures of post-MI LVRm.

Citing Articles

Extracellular RNA communication: A decade of NIH common fund support illuminates exRNA biology.

Amolegbe S, Johnston N, Ambrosi A, Ganguly A, Howcroft T, Kuo L J Extracell Vesicles. 2025; 14(1):e70016.

PMID: 39815775 PMC: 11735951. DOI: 10.1002/jev2.70016.


Approaches and Challenges in Characterizing the Molecular Content of Extracellular Vesicles for Biomarker Discovery.

Kumari S, Lausted C, Scherler K, Ng A, Lu Y, Lee I Biomolecules. 2025; 14(12.

PMID: 39766306 PMC: 11674167. DOI: 10.3390/biom14121599.


A perspective from the National Eye Institute Extracellular Vesicle Workshop: Gaps, needs, and opportunities for studies of extracellular vesicles in vision research.

Lee S, Klingeborn M, Bulte J, Chiu D, Chopp M, Cutler C J Extracell Vesicles. 2024; 13(12):e70023.

PMID: 39665315 PMC: 11635481. DOI: 10.1002/jev2.70023.


Extracellular vesicles, RNA sequencing, and bioinformatic analyses: Challenges, solutions, and recommendations.

Miceli R, Chen T, Nose Y, Tichkule S, Brown B, Fullard J J Extracell Vesicles. 2024; 13(12):e70005.

PMID: 39625409 PMC: 11613500. DOI: 10.1002/jev2.70005.


Therapeutic Potential of Natural Compounds Acting through Epigenetic Mechanisms in Cardiovascular Diseases: Current Findings and Future Directions.

Bontempo P, Capasso L, De Masi L, Nebbioso A, Rigano D Nutrients. 2024; 16(15).

PMID: 39125279 PMC: 11314203. DOI: 10.3390/nu16152399.


References
1.
Piccoli M, Gupta S, Viereck J, Foinquinos A, Samolovac S, Kramer F . Inhibition of the Cardiac Fibroblast-Enriched lncRNA Prevents Cardiac Fibrosis and Diastolic Dysfunction. Circ Res. 2017; 121(5):575-583. DOI: 10.1161/CIRCRESAHA.117.310624. View

2.
Creemers E, Tijsen A, Pinto Y . Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?. Circ Res. 2012; 110(3):483-95. DOI: 10.1161/CIRCRESAHA.111.247452. View

3.
Heydari B, Abdullah S, Pottala J, Shah R, Abbasi S, Mandry D . Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial. Circulation. 2016; 134(5):378-91. PMC: 4973577. DOI: 10.1161/CIRCULATIONAHA.115.019949. View

4.
Sanders-van Wijk S, van Empel V, Davarzani N, Maeder M, Handschin R, Pfisterer M . Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction. Eur J Heart Fail. 2015; 17(10):1006-14. DOI: 10.1002/ejhf.414. View

5.
Abbate A, Kontos M, Abouzaki N, Melchior R, Thomas C, Wallace Van Tassell B . Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies). Am J Cardiol. 2014; 115(3):288-92. DOI: 10.1016/j.amjcard.2014.11.003. View